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Objectives: We prospectively analyzed the association between drainage volume and development of complica-
tions to clarify the safety of early removal of chest tube after thoracoscopic lobectomy.
Methods: Between November 2001 and October 2007, 136 patients with suspected or histologically documented
lung cancer were enrolled. Patients with no air leak and increased drainage underwent removal of the chest tube
on the day after thoracoscopic lobectomy independent of the drainage volume. Patients were classified into three
groups as tertiles according to the drainage volume. Demographic and perioperative variables were compared
among the three groups. Age–sex adjusted odds ratios of the clinical variables associated with development of
complications were estimated. In addition, the odds ratios of the drainage volume for development of complica-
tions were estimated after adjusting for potentially important factors.
Results: One hundred patients underwent early removal of the chest tube. Almost all demographic and perioper-
ative variables showed no differences among the three groups (0–289 mL, n ¼ 33; 290–399 mL, n ¼ 33; and
400mL, n¼ 34). Tumors in a lower lobe, preoperative stage II or higher, 5 or more anatomic segments resected,
and advanced disease were all factors that were associated with higher odds ratios for complications. The drainage
volume was not associated with an increased morbidity, even after adjusting for these factors.
Conclusions: Early removal of chest tube on the day after thoracoscopic lobectomy, independently of the drain-
age volume, appears to be safe in well-selected patients.The pleural space is routinely drained after a pulmonary lo-
bectomy because re-expansion of the remaining lung tissue,
with the natural obliteration of the pleural space and without
any major fluid collection, is the desired clinical goal. Con-
ventionally, the chest tubes are kept in the pleural space until
air leakage has ceased and drainage is less than 150 mL for
the prior 24 hours.1 To date, to our knowledge, no clear ev-
idence concerning the proper drainage volume in regard to
the optimal timing of chest tube removal has been reported
in the literature.
Some investigators have reported a streamlining of the nor-
mal health care protocol to be potentially feasible after a pul-
monary resection through a muscle-sparing thoracotomy.
Cerfolio and associates2,3 demonstrated that chest tube re-
moval on postoperative days 2 to 3 was not associated with
any significant morbidity even in patients who underwent
major pulmonary resections. Nomori and colleagues4 re-
ported that the early removal of chest tubes on postoperative
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walking distance’’ while resulting in minimal complications
in patients with lung cancer who underwent a lobectomy. In
all three studies, a drainage volume of less than approxi-
mately 400 mL for the previous 24 hours, as well as the ab-
sence of air leakage, were the necessary requirements for
chest tube removal. However, the reasons for such a protocol
concerning the drainage volume for the timing of chest tube
removal were unclear.
With this background, we designed this prospective co-
hort study to elucidate the association between the drainage
volume and postoperative morbidity to clarify the safety
of early removal of chest tubes after lobectomy done by
video-assisted thoracic surgery (VATS).
PATIENTS AND METHODS
Patient Selection
Between November 2001 and October 2007, 136 patients with suspected
or histologically documented lung cancer were enrolled in this prospective
study. This series includes consecutive patients for whom the preoperative
intentionwas to perform aVATSmajor pulmonary resection, including a lo-
bectomy or bilobectomy, and to perform a mediastinal lymph node dissec-
tion. The indications for a VATS lobectomy were based on the standard
criteria for an open thoracotomy, including tumors up to 6 cm in diameter.
This study excluded any patients who underwent a pneumonectomy. The
patients who were included had an Eastern Cooperative Oncology Group
performance status of 0 to 2. All patients with radiologically suggestive lim-
ited single-station N2 disease were eligible for this study. This series in-
cluded 1 patient who underwent induction chemotherapy. In patients with
preoperative stage IV, only treatable brain metastasis was included. The
Institutional Review Board of Clinical Research of our hospital ethicallyrgery c June 2009
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approved this study, and informed consent for this study was obtained from
all patients.
Surgical Technique
Under single-lung anesthesia, 4 incisions were used in the majority of the
patients in this series. A utility thoracotomy was placed in the third or fourth
intercostal space and consisted of a 5- to 7-cm incision. The remaining 3 in-
cisions for the 12-mm trocars were made. The pulmonary vessels and bron-
chi were then individually divided and an extensive dissection of the
mediastinal lymph nodes was thoracoscopically performed, as previously
reported.5-7 After pneumostasis and hemostasis were confirmed, a 28F chest
tube was placed in the apical and posterior pleural space through the trocar
wound on the anterior axillary line. Moreover, a small 7F backup tube was
placed within the dead space by thoracoscopic guidance for all patients
to prevent excessive fluid accumulation, potentially caused by the early
removal of the 28F tube. The wounds were then closed. Only a 28F tube
was kept on suction with a negative pressure of 10 cm H2O until removal
in all patients to decrease the size of the dead space.
Study Design and Data Acquisition
We established the clinical criteria for this early removal strategy of the
chest tube as follows, with reference to a previous work by Russo and
coworkers.8
1. Absence of air leakage
2. Absence of an increased drainage volume every 6 hours after surgery
3. Absence of a densely bloody, purulent, or cloudy pleural effusion
4. Absence of atelectasis on postoperative chest radiograph
5. Orotracheal tube removal after recovery from anesthesia
The patients who met these criteria underwent early removal of the 28F
chest tube on the day afterVATS lobectomy, independent of the drainagevol-
ume. The 7F backup tube was removed on the fourth postoperative daywhen
allwent smoothly. The patient underwent rescue drainage through the 7F tube
when he or she had subjective symptoms (eg, cough, dyspnea on exertion, or
chest discomfort) or compression atelectasis on chest x-ray films.
The operative mortality included all patients who died within the first 30
days after surgery or during the hospitalization. The postoperativemorbidity
included all patients who had complications during the hospitalization and
after discharge from the hospital. The complete follow-up data were
obtained from the records of the postdischarge visits and from the regular
radiographic follow-up.
Statistical Analysis
The subjects were classified into three groups as tertiles according to the
drainage volume for 24 hours after the operation. The demographic and
perioperative variables including complications were compared among
the three groups. Continuous variables were expressed as the mean  stan-
dard deviation and compared by analysis of variance. Categorical variables
were compared by either the c2 or Fisher’s exact test. Age–sex adjusted
odds ratios of the clinical variables associated with the development of com-
plications were then estimated. In addition, the odds ratios of the drainage
volume for the development of complication were estimated, respectively
adjusting for several factors that were deemed of potential importance on
the age–sex adjusted analysis. Owing to the small sample size and the pres-
ence of zero cells, we applied an exact logistic regression to estimate the
odds ratios of the clinical variables for the development of complication9,10
inasmuch as regular logistic regression for the analysis of skewed or sparseThe Journal of Thoracic and Cdata sets is unreliable. All statistical analyses were carried out with SAS ver-
sion 8.02 (SAS Institute, Inc, Cary, NC) software package.11
RESULTS
Demographic Data
AVATS lobectomy was successfully performed in all pa-
tients, and there were no conversions to an open thoracot-
omy. The subjects accounted for 60% of the patients
undergoing a VATS major pulmonary resection at our hos-
pital. After the operation, 36 patients who had an air leak
(n ¼ 34), malignant effusion showing gradual increase
(n ¼ 1), or chylothorax showing cloudy effusion (n ¼ 1)
were excluded from this study. The remaining 100 patients
underwent an early removal of the 28F chest tube on the
day after the operation, independent of the drainage volume
(median, 330 mL; range, 60–1030 mL).
The median subject age was 68 years (range, 30–86
years); 26 patients were aged 75 years or older. The subjects
included 45 women and 55 men. A poor functional status, as
defined by a performance status of 2, was seen in 2 patients.
A smoking history was present in 60 patients (mean pack-
years of tobacco smoking, 47). The mean forced expiratory
volume in 1 second was 2.2 L (range, 1.2–3.9 L). The co-
morbidity of this series included 17 patients with chronic
obstructive pulmonary disease, 10 patients with diabetes
mellitus, 6 patients with interstitial pneumonia, and 6 pa-
tients with long-standing pleuritis. No patients underwent
steroid therapy. The preoperative stages were as follows:
IA in 55 patients, IB in 27, IIA in 2, IIB in 10, IIIA in 4,
and IV in 2. The demographic variables showed no differ-
ences among the three groups according to the drainage vol-
ume (0–289 mL, n ¼ 33; 290–399 mL, n ¼ 33; and 400
mL, n ¼ 34) (Table 1).
Perioperative Data
The thoracoscopic exploration showed a broad pleural ad-
hesion in 15 patients. The treatment modality was a lobec-
tomy in 96 patients and a bilobectomy in 4 patients. The
distribution of the lobectomies was as follows: right upper
lobe in 25 patients, middle lobe in 3, right lower lobe in
25, right upper and middle lobe in 2, right middle and lower
lobe in 2, left upper lobe in 24, and left lower lobe in 19. The
mean number of anatomic pulmonary segments resected was
4.3  1.0 segments. The mean operative time and bleeding
volume were 295  77 minutes and 114  96 mL, respec-
tively. The pathologic analysis included primary lung cancer
in 90 patients, secondary lung cancer in 4, and benign tumor
in 6. In the 90 patients with primary lung cancer, the postop-
erative stages were as follows: IA in 43 patients, IB in 17,
IIA in 5, IIB in 4, IIIA in 9, IIIB in 9, and IV in 3 (Table 2).
No mortality was observed. There were 18 complications
in 16 patients. Those complications were seen in patients
with only primary lung cancer, although all the subjects
underwent uniform surgical treatment consisting ofardiovascular Surgery c Volume 137, Number 6 1395
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lymph nodes. The distribution of complications is shown in
Table 2. The 2 patients who had pneumonia had undergone
a right lower lobectomy. One had poor pulmonary reserve
after a contralateral lobectomy and another contracted a chla-
mydial infection after discharge. All 4 patients who had late
pleural effusion requiring thoracentesis had also undergone
a right lower lobectomy (Table 3), although the remaining
96 patients had no trouble with pleural effusion. Only 1 pa-
tient underwent rescue drainage through the 7F tube, al-
though 99 patients underwent the removal of an unused 7F
small tube on the fourth postoperative day. The detrimental
event of the patient was identified as a late pleural effusion
requiring thoracentesis. Another patient who had a drainage
volume of more than 1000 mL for 24 hours after surgery un-
derwent removal of the chest tube because he finally met the
TABLE 1. Demographic data according to the drainage volume for
24 hours
Variable
Drainage volume (mL)
P
value
0–289 290–399 400
205.8 ± 50.6
(60–285)
(n ¼ 33)
333.8 ± 34.4
(290–390)
(n ¼ 33)
519.6 ± 127.4
(400–1030)
(n ¼ 34)
Age (y) 66.0  7.9 67.7  12.2 67.9  9.4 .678*
Sex: male 16 (48%) 16 (48%) 23 (68%) .189y
Performance
status: 0
31 (94%) 29 (88%) 31 (91%) .291z
Tobacco use
(pack-y)
25.7  32.3 31.3  30.0 28.0  23.9 .728*
COPD 3 (9%) 7 (21%) 7 (21%) .335y
Affected side:
right
16 (48%) 20 (61%) 21 (62%) .480y
Tumor in lower
lobe
12 (36%) 15 (45%) 19 (56%) .276y
Preoperative stage
I (A, B) 23 (19, 4) 27 (14, 13) 32 (22, 10) .152z
II (A, B) 7 (1, 6) 4 (1, 3) 1 (0, 1)
III (A, B) 2 (2, 0) 1 (1, 0) 1 (1, 0)
IV 1 1 0
COPD, Chronic obstructive pulmonary disease. The values are presented as a number
(percentage of variables) or the mean standard deviation. *P values are derived from
the analysis of variance. yP values are derived from the c2 test. zP values are derived
from Fisher’s exact test.1396 The Journal of Thoracic and Cardiovascular Searly removal criteria after the dilution of his bloody effu-
sion was confirmed. No associations between the surgical
site and complications were observed, except for pneumonia
and the late pleural effusion. No subjects had pleural infec-
tious disease such as empyema at a mean follow-up of 34
months after the operation in this study. No perioperative
variables, except for bleeding volume, showed any differ-
ences among the three groups according to the drainage vol-
ume (Table 2).
TABLE 2. Perioperative data according to the drainage volume for
24 hours
Variable
Drainage volume (mL)
P
value
0–289
(n ¼ 33)
290–399
(n ¼ 33)
400
(n ¼ 34)
Broad pleural adhesion 3 (9%) 5 (15%) 7 (21%) .447z
No. of segments resected 4.2  1.0 4.4  1.0 4.3  1.0 .686*
Operative time (min) 310  79 281  73 293  81 .315*
Bleeding volume (mL) 89  70 105  71 149  126 .027*
Primary lung cancer 31 (94%) 28 (85%) 31 (91%) .585z
Postoperative stage
I (A, B) 17 (14, 3) 22 (14, 8) 21 (15, 6) .254z
II (A, B) 5 (2, 3) 0 (0, 0) 4 (3, 1)
III (A, B) 8 (5, 3) 5 (1, 4) 5 (3, 2)
IV 1 1 1
Epidural tube
duration (d)
1.4  1.1 1.4  1.1 1.2  0.4 .763*
Analgesic requirement
(times/wk)
8.0  5.8 5.8  4.4 6.9  5.0 .217*
Complication 6 (18%) 5 (15%) 5 (15%) .915y
Atrial fibrillation 2 2 0
Ileus 0 0 1
Pleural effusion
requiring thoracentesis
1 1 2
Pneumonia 2 0 0
Pneumothorax 1 0 2
Sputum retention
requiring bronchoscopy
2{ 2 0
Postop hospital stay (d) 12.3  7.3 11.5  4.5 13.1  8.9 .647*
The values are presented as a number (percentage of variables) or the mean standard
deviation. *P values are derived from the analysis of variance. yP values are derived
from the c2 test. zP values are derived from Fisher’s exact test. {After sputum reten-
tion, one contracted pneumonia and the other had atrial fibrillation. An indomethacin
suppository and/or the intramuscular administration of pentazocine were used for post-
operative pain control in addition to the use of epidural anesthesia.TABLE 3. Characteristics of the 4 patients requiring thoracentesis
Patient No.
(age [y], sex)
Disease
and stage Surgery
Bleeding during
surgery (mL)
Drainage volume
for 24 h after
surgery (mL)
No. of days
until thoracentesis
after surgery
Indication
including
symptoms
Volume of
thoracentesis
fluid (mL)
1 (52, M) PLC, IA RLL 60 580 4* Compression atelectasis 270
2 (59, M) PLC, IB RLL 125 1030 22 Cough 420
3 (74, F) PLC, IV RLL 70 205 8 Compression atelectasis 300
4 (80, M) PLC, IA RLL 100 295 11, 14 Chest compression 970, 700
Pt, Patient; M, male; F, female; PLC, primary lung cancer; RLL, right lower lobectomy. *The patient underwent rescue drainage through the 7F tube on postoperative day 4.urgery c June 2009
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The age–sex adjusted odds ratios of the clinical variables
associated with the development of complications are pre-
sented in Table 4. The variables that were deemed of poten-
tial importance on the age–sex adjusted analysis were tumor
location, preoperative stage, the number of anatomic seg-
ments resected, and the severity of the disease. The patients
with a tumor in a lower lobe had a higher odds ratio for
complication than did those with a tumor in the upper or
middle lobe. A preoperative stage of II or higher also
showed a higher odds ratio than in stage I. The number of
segments resected was also associated with the risk of com-
plication. The subjects with advanced disease had a higher
odds ratio than those with localized disease. When the anal-
yses were limited to the subjects with primary cancer,
advanced disease of postoperative stage II to IV also
showed a higher odds ratio (5.66; 95% confidence interval,
1.55–23.95; P ¼ .0061) than did localized disease of post-
operative stage I.
On the other hand, the drainage volume was not associ-
ated with increased morbidity. Furthermore, the multivari-
able odds ratios of the drainage volume adjusted for tumor
location, preoperative stage, number of segments resected,
or severity showed no association with the development of
complications (Table 5).
DISCUSSION
After an uncomplicated VATS wedge resection of the
lung, Russo and associates8 have reported that the early re-
moval of chest tubes, within 90 minutes of surgery, allowed
for less postoperative pain, fewer chest radiographs, and
earlier discharge from the hospital than the traditional tube
management, regardless of comparable morbidity. Lately,
several studies on postoperative management without use
of chest tubes after a VATS minor operation have demon-
strated that the lack of tube drainage was not associated
with any increased morbidity, and this protocol resulted in
shorter hospital stays than did traditional tube manage-
ment.12,13 Each study has emphasized that this early postop-
erative drainage management is a safe and effective practice
in well-selected patients, absent an air leak or increased
drainage including bleeding. The fluid collection in the
dead space after a wedge resection may be negligibly small.
The benefits of VATS, such as smaller incisions and re-
duced trauma, may also be responsible for the fluid collec-
tion. The early removal of chest tubes is likely be more
economical and less painful than the traditional tube man-
agement, if it is successful after a VATS major pulmonary
resection.
With regard to a major pulmonary resection, there are pre-
cious few reports addressing the issue of the early removal of
chest tubes after a lobectomy. Generally, the decision to re-
move the tube is likely to be based on the lack of air leak, theThe Journal of Thoracic and Cabsence of a hemothorax, and drainage of less than 150 mL
for the last 24 hours after a lobectomy through an open tho-
racotomy.1 In the patients who underwent a VATS major
pulmonary resection, McKenna and coworkers14 have re-
ported that early removal of the chest tube is feasible with
minimal complications when the drainage is less than 300
TABLE 4. Age–sex adjusted odds ratios of the clinical variables
associated with the development of complications
Variable No.
No. of
patients
with PC (%)
Odds
ratio
95%
CI
P
value
Drainage volume (mL)
0–289 33 6 (18.2%) Reference
290–399 33 5 (15.2%) 0.71 0.14–3.36 .875
400 34 5 (14.7%) 0.62 0.13–2.85 .701
Age 1.04 0.98–1.11 .170
Sex
Female 45 4 (8.9%) Reference
Male 55 12 (21.8%) 2.83 0.78–13.04 .135
Performance status
0 91 13 (14.3%) Reference
1 or 2 9 3 (33.3%) 2.22 0.27–15.00 .582
COPD
No 83 11 (13.3%) Reference
Yes 17 5 (29.4%) 2.30 0.52–9.07 .312
Tumor location
Upper or middle 54 3 (5.6%) Reference
Lower 46 13 (28.3%) 6.01 1.44–36.38 .010
Preoperative stage
I 82 9 (11.0%) Reference
II-IV 18 7 (38.9%) 4.42 1.11–17.32 .034
Pleural adhesion
No or narrow 85 13 (15.3%) Reference
Broad 15 3 (20.0%) 1.08 0.16–5.37 1.000
No. of segments resected
0–3 26 0 (0%) Reference
3.1–4.9 21 4 (19.0%) 7.77 0.88–infinity .067
5 53 12 (22.6%) 9.31 1.40–infinity .017
Operative time (min)
0–255 33 4 (12.1%) Reference
256–315 33 4 (12.1%) 0.86 0.14–5.18 1.000
316 34 8 (23.5%) 1.77 0.40–9.28 .603
Bleeding volume (mL)
0–60 35 1 (2.9%) Reference
61–125 31 7 (22.6%) 8.33 0.96–399.53 .057
126 34 8 (23.5%) 6.46 0.71–321.47 .131
Disease
Primary cancer 90 16 (17.8%) Reference
Secondary cancer 4 0 (0%) 1.02 0.00–8.89 1.000
Benign tumor 6 0 (0%) 0.78 0.00–6.37 .840
Severity
Localized disease 66 5 (7.6%) Reference
Advanced disease 34 11 (32.4%) 5.22 1.46–21.67 .008
PC, Postoperative complication; CI, confidence interval; COPD, chronic obstructive
pulmonary disease; localized disease includes postoperative stage I primary lung can-
cer (n¼ 60) and benign tumor (n¼ 6); advanced disease includes postoperative stage
II–IV primary lung cancer (n ¼ 30) and secondary cancer (n ¼ 4).ardiovascular Surgery c Volume 137, Number 6 1397
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two studies concerning an open thoracotomy, the safety mar-
gin of the drainage volume for the last 24 hours was empir-
ically established as approximately 400 mL.2-4 This study, in
which patients who had drainage volume exceeding the 400
mL accounted for one third of the subjects, showed that even
excessive drainage volume was not associated with in-
creased complication. Therefore, the drainage volume for re-
moval may not be confined to 400 mL or less, although the
early removal strategy of chest tubes must be strictly applied
to the patient.
The pleural fluid originates from the parietal pleura and is
resorbed by the visceral pleura. The pleural effusion develops
when the amount of fluid that enters the pleural space exceeds
the amount that can be removed.15 Therefore, the removal of
a pulmonary lobe with a large pleural area, such as a right
TABLE 5. Multivariable odds ratios of the drainage volume for
development of complications
Model Variable Odds ratio 95% CI P value
1 Drainage volume (mL)
0–289 Reference
290–399 0.53 0.09–2.77 .611
400 0.37 0.06–1.98 .318
Tumor location
Upper or middle Reference
Lower 7.18 1.61–47.01 .006
2 Drainage volume (mL)
0–289 Reference
290–399 1.10 0.20–6.16 1.000
400 1.23 0.21–7.62 1.000
Preoperative stage
I Reference
II–IV 4.57 1.01–21.15 .048
3 Drainage volume (mL)
0–289 Reference
290–399 0.68 0.13–3.32 .834
400 0.56 0.11–2.76 .627
No. of segments resected
0–3 Reference
3.1–4.9 8.10 0.91–infinity .061
5 9.22 1.40–infinity .017
4 Drainage volume (mL)
0–289 Reference
290–399 1.03 0.19–5.41 1.000
400 0.86 0.17–4.38 1.000
Severity
Localized disease Reference
Advanced disease 4.97 1.34–20.77 .012
Model 1 presents the odds ratio adjusted by age, sex, drainage volume, and tumor
location. Model 2 presents the odds ratio adjusted by age, sex, drainage volume, and
preoperative stage. Model 3 presents the odds ratio adjusted by age, sex, drainage vol-
ume, and number of segments resected.Model 4 presents the odds ratio adjusted by age,
sex, drainage volume, and postoperative stage of primary lung cancer including benign
tumor and secondary cancer. CI, Confidence interval; localized disease includes
postoperative stage I primary lung cancer (n¼ 60) and benign tumor (n¼ 6); advanced
disease includes postoperative stage II–IV primary lung cancer (n¼ 30) and secondary
cancer (n ¼ 4).1398 The Journal of Thoracic and Cardiovascular Slower or left upper lobe, creates a temporary fluid resorption
disturbance. The increased frequency of an excessive pleural
effusion after a right lower lobectomy seems to be closely as-
sociated with middle lobe atelectasis. Because a large dead
space exists in the dorsal and inferior divisions of the pleural
cavity, the fluid is apt to accumulate under the influence of
gravity. A middle lobe atelectasis often occurs because the
middle lobe bronchus is spindly and also apt to become
kinked in contrast to the lingular bronchus, and it accelerates
an increased amount of pleural effusion. Intrathoracic bleed-
ing, as a barrier to the visceral pleura either during or after
surgery, may also decrease the amount of fluid that can be re-
moved, as shown by Table 2, or by the presentation of patient
2 in Table 3. Although excessive suction with a negative
pressure increases the amount of fluid that enters the pleural
space, the established negative pressure of this seriesmay not
have been excessive because 96% of all subjects did not have
any symptomatic pleural effusion.
With the re-expansion of the remaining lung after surgery,
the pleural space is usually obliterated within several days to
a week. In most instances, the fluid that remains is resorbed
or becomes organized. Although an asymptomatic fluid ac-
cumulation occasionally remains for a long period, the dis-
ruption of the balance of the fluid movement leads to an
excessive and symptomatic fluid collection in the pleural
space. Conlan16 reported that 3% of persistent fluid spaces
become complicated. No subjects in this study had pleural
infectious disease such as empyema despite a mean fol-
low-up of 34 months after surgery, although further careful
surveillance is needed for some time in the future.
The main limitation of this study is the small cohort, and
this study may be hard to accept for surgeons who engage in
traditional tube management. We included all complications
in the analyses owing to the small number of complications
and ambiguity to define the complications related to pleural
effusion. Further investigation of the complications limited
to those related to the accumulation of pleural effusion is
thus warranted. It is unknown whether the benefits of
VATS allow the early removal of chest tubes, because this
study does not include a comparative study with an open
thoracotomy. However, this early removal management of
the chest tube is a novel treatment protocol, which is consid-
ered to potentially improve the quality of life of postopera-
tive patients.
The early removal of the chest tube on the day after
a VATS lobectomy, independent of the drainage volume,
appears to be a safe treatment protocol in well-selected pa-
tients without air leakage, increased drainage, cloudy effu-
sion, atelectasis, or episodes of intrathoracic bleeding after
surgery. Nevertheless, further careful surveillance is needed,
especially for patients undergoing a right lower lobectomy.
We believe that further investigation is warranted to confirm
our findings and to help identify the optimal tube manage-
ment protocol.urgery c June 2009
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